Individual serum from SjS mice treated with the low-dose of LL-CFA/I exhibited significantly (P < 0.05) less speckled ANA than PBS- and LL vector-treated groups (Fig. 2f). The gene discussed is BTG3; the disease is Schwartz-Jampel syndrome.